| 12275729 |
Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
Yongqi Deng, Abdelghani Achab, David Jonathan Bennett, Indu T. Bharathan, Craig R. Gibeau +8 more |
2025-04-15 |
|
| 12264134 |
Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
Dane Clausen, Ping Chen, Liangqin Guo, Yongxin Han, Shuwen He +10 more |
2025-04-01 |
|
| 12180226 |
Spirotricycle RIPK1 inhibitors and methods of uses thereof |
Abdelghani Achab, Zachary G. Brill, Jenny Lorena Rico Duque, Joey L. Methot, Phieng Siliphaivanh +3 more |
2024-12-31 |
$180,761,000 |
| 12157727 |
Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
Yongxin Han, Yongqi Deng, Hua Zhou, Meredeth A. McGowan, Hongjun Zhang +3 more |
2024-12-03 |
$1,481,364,000 |
| 12152019 |
Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors |
Dane Clausen, Ping Chen, Liangqin Guo, Yongxin Han, Shuwen He +5 more |
2024-11-26 |
$487,297,000 |
| 12091405 |
Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors |
Dane Clausen, Liangqin Guo, Yongxin Han, Shuwen He, Joseph A. Kozlowski +7 more |
2024-09-17 |
$1,535,554,000 |
| 11992489 |
Substituted tetrahydroquinoline compounds as indoleamine 2,3-dioxygenase inhibitors |
Dane Clausen, Yongxin Han, Alexander Pasternak, Li Xiao, Hongjun Zhang |
2024-05-28 |
$153,549,000 |
| 11498904 |
Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
Yongxin Han, Abdelghani Achab, Indu T. Bharathan, Derun Li, Nunzio Sciammetta +1 more |
2022-11-15 |
$883,400,000 |
| 11478461 |
[1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors |
Liangqin Guo, Hongjun Zhang, Ping Chen, Dane Clausen, Yongxin Han +6 more |
2022-10-25 |
$350,597,000 |
| 11319283 |
Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
Meredeth A. McGowan, Abdelghani Achab, Yongxin Han, Derun Li, Jongwon Lim +6 more |
2022-05-03 |
$363,616,000 |
| 11230547 |
Purine inhibitors of human phosphatidylinositol 3-kinase delta |
Meredeth A. McGowan, Jason Katz, Matthew Christopher, Hua Zhou, David J. Witter +5 more |
2022-01-25 |
$195,577,000 |
| 11208407 |
Substituted phenyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
Hua Zhou, Abdelghani Achab, Yongxin Han, Derun Li, Meredeth A. McGowan +3 more |
2021-12-28 |
$153,354,000 |
| 11179389 |
Purine inhibitors of human phosphatidylinositol 3-kinase delta |
Meredeth A. McGowan, Jason Katz, Hua Zhou, David J. Witter, Chaomin Li +5 more |
2021-11-23 |
$242,106,000 |
| 11111232 |
Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
Catherine White, Abdelghani Achab, Indu T. Bharathan, Yongxin Han, Derun Li +7 more |
2021-09-07 |
$168,031,000 |
| 11103493 |
Substituted pyridinyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
Hua Zhou, Yongxin Han, Meredeth A. McGowan, Nunzio Sciammetta, Catherine White +1 more |
2021-08-31 |
$154,425,000 |
| 10995085 |
Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
Yongxin Han, Abdelghani Achab, Yongqi Deng, Craig R. Gibeau, Brett A. Hopkins +8 more |
2021-05-04 |
$204,878,000 |
| 10988487 |
Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
Kun Liu, Abdelghani Achab, Purakkattle Biju, Timothy A. Cernak, Yongqi Deng +10 more |
2021-04-27 |
$169,438,000 |
| 10647705 |
Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
Yongxin Han, Abdelghani Achab, Yongqi Deng, Craig R. Gibeau, Brett A. Hopkins +8 more |
2020-05-12 |
$155,382,000 |
| 10538497 |
Compounds as indoleamine 2,3-dioxygenase inhibitors |
Yongxin Han, Abdelghani Achab, Purakkattle Biju, Yongqi Deng, Liangqin Guo +9 more |
2020-01-21 |
$220,499,000 |
| 7932251 |
6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives |
Jiaqiang Cai, Zoran Rankovic, Philip Jones, David Jonathan Bennett |
2011-04-26 |
|
